Pharmaceutical public affairs

Pharmaceutical policy · tiger.PHARMA

Pharmaceutical public affairs

Pharmaceutical public affairs connects policy, market evidence, stakeholder communication and patient-supply implications in a clear, defensible engagement strategy.

Discuss your challenge →
Expert team coordinating public affairs and communication with supply partners

Services for

Pharmaceutical public affairs

Services for
Pharmaceutical public affairs

GDP.secure.QMS.smart — pharma expertise with a clear operational focus.

Public affairs

Supply · market · resilience

Public affairs

Pharmaceutical public affairs connects policy, market evidence, stakeholder communication and patient-supply implications in a clear, defensible engagement strategy.

We develop suitable models for hospital pharmacies, critical supply, retail concepts and stakeholder communication – factual, documented and executable.

tiger.PHARMA Expertise

Topics we master

Secure supply and special sourcing

Secure supply and special sourcing

For clinical, critical or international needs, alternatives, supply chains, qualification and evidence are managed as one process.

  • Demand, risk and availability analysis
  • Special sourcing, import and escalation routes
  • GDP-compliant storage, transport and evidence
Design market entry and fulfilment

Design market entry and fulfilment

For manufacturers and retail, assortment, product requirements, distribution and B2B/B2C fulfilment are aligned.

  • Market, product and channel strategy
  • Labelling, data, quality and partner qualification
  • Omnichannel, last-mile and returns model
Connect regulation and stakeholders

Connect regulation and stakeholders

Regulatory change, supply data and interests are turned into clear, defensible communication.

  • Monitoring and structured situation reports
  • Stakeholder mapping and engagement
  • Crisis communication and fact-based positioning

Contact

Discuss your challenge

Contact in 10 seconds – clear, direct and in your language.

Contact →